Aspirin May Decrease Death From Lethal Prostate Cancer, Harvard Medical School Study

Men who take aspirin regularly may have a lower risk of dying from prostate cancer, a new study suggests.

“We found that regular aspirin intake after prostate cancer diagnosis decreased the risk of prostate cancer death by almost 40 percent,” said lead researcher Dr. Christopher Allard, a urologic oncology fellow at Harvard Medical School in Boston.

MORE ON THIS TOPIC